UK markets close in 5 hours 31 minutes

Guardant Health, Inc. (GH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.04-0.22 (-0.52%)
At close: 04:00PM EDT
42.04 0.00 (0.00%)
After hours: 06:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close42.26
Bid0.00 x 1200
Ask0.00 x 1200
Day's range41.47 - 43.53
52-week range27.65 - 133.82
Avg. volume1,491,864
Market cap4.285B
Beta (5Y monthly)0.72
PE ratio (TTM)N/A
EPS (TTM)-4.13
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est117.73
  • Business Wire

    Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

    PALO ALTO, Calif., June 13, 2022--Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, giving the company full control over operations throughout the Asia, Middle East and Africa region.

  • Motley Fool

    Why Shares of Guardant Health Dropped 33.6% in May

    It's a bit early for investors to jump the ship regarding Guardant because the biotech stock still has plenty of good long-term prospects. The test will compete with the Galleri blood-based cancer screening by the Grail unit of Illumina and a the Cologuard fecal screening by Exact Sciences. Investors are also watching the outcome of a lawsuit, filed in March by Illumina, that claims that Guardant and two of its founders -- former employees of Illumina -- used Illumina's propriety information to help them launch Guardant.

  • Business Wire

    Guardant Health to Participate in Upcoming June Investor Conferences

    REDWOOD CITY, Calif., May 26, 2022--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.